873306-32-2

Basic information

• Product Name: Furo[2,3-d]pyrimidine, 4-bromo-5,6-diphenyl-
• CAS NO: 873306-32-2
• Molecular Formula: C18H11BrN2O
• Molecular Weight: 351.202
• Mol File: 873306-32-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Furo[2,3-d]pyrimidine, 4-bromo-5,6-diphenyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Furo[2,3-d]pyrimidine, 4-bromo-5,6-diphenyl-(873306-32-2)
• EPA Substance Registry System: Furo[2,3-d]pyrimidine, 4-bromo-5,6-diphenyl-(873306-32-2)

Safety Data

• Hazardous Substances Data: 873306-32-2(Hazardous Substances Data)

Upstream product

• 106561-29-9 5,6-diphenyl-3H-furo[2,3-d]pyrimidin-4-one 

Downstream Products

• 873305-35-2 5,6-diphenyl-4-[(S)-(tetrahydrofuran-2-yl)-methyl]aminofuro[2,3-d]pyrimidine 

Relevant articles and documents

FURANOPYRIMIDINES

The present invention relates to furanopyrimidine compounds having the general Formula (I) and stereoisomers, tautomers, solvates, pharmaceutically acceptable salts and derivatives, and prodrugs thereof. The invention also includes pharmaceutical compositions comprising a compound of Formula (I), methods of treating various diseases and conditions in a mammal, including inflammation, inhibition of T cell activation, proliferation, arthritis, organ transplant, ischemic or reperfusion injury, myocardial infarction, stroke, multiple sclerosis, inflammatory bowel disease, Crohn's disease, lupus, hypersensitivity, type 1 diabetes, psoriasis, dermatitis, Hashimoto's thyroiditis, Sjogren's syndrome, autoimmune hyperthyroidism, Addison's disease, autoimmune diseases, glomerulonephritis, allergic diseases, asthma, hayfever, eczema, cancer, colon carcinoma and thymoma, comprising administering to the mammal a therapeutically effective amount of a compound of Formula (I). The invention also relates to methods of manufacturing medicaments, which comprise one or more compounds of Formula (I).